However, the mechanism behind Ozempic face has not been fully understood
Over the last few years, Recent surveys show that about one in every eight adults in the United States or 12% are currently taking a GLP-1 medication like Wegovy or Zepbound for weight loss or treatment of a chronic condition
These agents include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), among others
Conditions such as rheumatoid arthritis, lupus, multiple sclerosis, and Hashimotos thyroiditis are common examples
The treatment policy estimand evaluated the effect of treatment regardless of treatment discontinuation or initiation of rescue medication [60], comparable to an intention-to-treat approach
Take Control of Your Health Today Losing weight can be challenging, but you dont have to do it alone